First Impression: Cochlear (COH) Interim Result

Bell Potter

Stockbroker

Cochlear implant (CI is 62% of total sales rev) sales revenue up 4% to $377.1m and implant units up 10% to 16234. | Services (sound processor upgrades and accessories is 24% of total sales reve) sales revenue down 1% to $144.8m. | Acoustic (Bone conduction and acoustic implants is 14% of total sales rev) up 13% to $82.5m | Net operating cash flow up 39% to $102.3m | Outlook: FY17 net profit guidance maintained at $210-225m, up around 10-20% on FY16. Our FY17 NPAT estimate stands at $223m, in-line with Consensus | Today’s share price reaction: na- market opens 10.00 am (previous close $133.40).


1 stock mentioned

Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

trending on livewire
Get the best of Livewire by signing up to our popular daily newsletter